Reference page — cumulative record through Monday, October 19, 2026 UTC. Reference pages update as the archive grows; only dated daily editions are immutable pages of record.
Backstage
Product reference — Backstage by Backstage · sector: Other. Cumulative disclosure record for this product across the archive.
Product totals
| All-time | YTD | |
|---|---|---|
| CVEs | 44 | 44 |
| KEV entries | 0 | 0 |
| KEV/100 | Med CVSS | Med EPSS | C | H | M | L |
|---|---|---|---|---|---|---|
| 0.0 | 6.5 | .0028 | 1 | 15 | 26 | 2 |
KEV/100 = KEV entries ÷ CVEs × 100. Med CVSS / Med EPSS are medians over this product's disclosures. C/H/M/L = disclosures by CVSS severity band.
Monthly disclosures
Trend (by first-seen month, full archive): ▁▁█
| Month | New CVEs |
|---|---|
| 2026-08 | 1 |
| 2026-09 | 1 |
| 2026-10 | 42 |
Notable CVEs
Ranked by the published formula: KEV → EPSS → CVSS → CVE ID.
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-88064 | 8.8 | 67.2 | HIGH | — | 2026-09-16 |
| CVE-2026-106501 | 9.6 | 40.2 | CRITICAL | — | 2026-10-06 |
| CVE-2026-106558 | 8.8 | 39.2 | HIGH | — | 2026-10-07 |
| CVE-2026-106510 | 7.7 | 37.7 | HIGH | — | 2026-10-07 |
| CVE-2026-106503 | 8.1 | 30.6 | HIGH | — | 2026-10-06 |
| CVE-2026-106509 | 8.8 | 29.3 | HIGH | — | 2026-10-06 |
| CVE-2026-106490 | 6.5 | 28.3 | MEDIUM | — | 2026-10-06 |
| CVE-2026-106500 | 8.5 | 25.4 | HIGH | — | 2026-10-06 |
| CVE-2026-106455 | 7.7 | 24.9 | HIGH | — | 2026-10-06 |
| CVE-2026-106559 | 6.5 | 24.8 | MEDIUM | — | 2026-10-07 |
| CVE-2026-106486 | 8.5 | 24.0 | HIGH | — | 2026-10-06 |
| CVE-2026-106560 | 6.5 | 22.8 | MEDIUM | — | 2026-10-07 |
| CVE-2026-106460 | 6.8 | 22.7 | MEDIUM | — | 2026-10-06 |
| CVE-2026-106505 | 8.5 | 22.5 | HIGH | — | 2026-10-06 |
| CVE-2026-106507 | 6.5 | 22.1 | MEDIUM | — | 2026-10-06 |
Recent CVEs
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-106495 | 4.3 | 13.8 | MEDIUM | — | 2026-10-12 |
| CVE-2026-106563 | 6.5 | 12.2 | MEDIUM | — | 2026-10-07 |
| CVE-2026-106558 | 8.8 | 39.2 | HIGH | — | 2026-10-07 |
| CVE-2026-106562 | 4.3 | 8.8 | MEDIUM | — | 2026-10-07 |
| CVE-2026-106556 | 7.7 | 16.2 | HIGH | — | 2026-10-07 |
| CVE-2026-106559 | 6.5 | 24.8 | MEDIUM | — | 2026-10-07 |
| CVE-2026-106561 | 5.0 | 8.8 | MEDIUM | — | 2026-10-07 |
| CVE-2026-106510 | 7.7 | 37.7 | HIGH | — | 2026-10-07 |
| CVE-2026-106560 | 6.5 | 22.8 | MEDIUM | — | 2026-10-07 |
| CVE-2026-106557 | 7.7 | 21.0 | HIGH | — | 2026-10-07 |
| CVE-2026-106492 | 7.6 | 13.9 | HIGH | — | 2026-10-06 |
| CVE-2026-106487 | 3.5 | 16.5 | LOW | — | 2026-10-06 |
| CVE-2026-106460 | 6.8 | 22.7 | MEDIUM | — | 2026-10-06 |
| CVE-2026-106455 | 7.7 | 24.9 | HIGH | — | 2026-10-06 |
| CVE-2026-106503 | 8.1 | 30.6 | HIGH | — | 2026-10-06 |
KEV entries
No entries in the CISA KEV catalog.
Related
Vendor: Backstage — all products and the full vendor record.
Methodology
A product is a (vendor, product) pair as named in the affected-product data. Rate statistics are arithmetic over published figures. Counts key to first-seen day. Raw counts are not comparable across products; this is a reference page assembled from the public record, not a ranking by our judgment.
Sources. CVE Program (cvelistV5), NVD (NIST), CISA KEV, FIRST EPSS.